WJPR Citation New

  All Since 2020
 Citation  8502  4519
 h-index  30  23
 i10-index  227  96

Login

Best Article Awards

World Journal of Pharmaceutical Research (WJPR) is giving Best Article Award in every Issue for Best Article and Issue Certificate of Appreciation to the Authors to promote research activity of scholar.
Best Paper Award :
Dr. Dhrubo Jyoti Sen
Download Article: Click Here

Search

Track Your Article

Abstract

ANGIOTENSIN RECEPTOR BLOCKER

Rekha Olivia* and Yulistiani

Abstract

Angiotensin II receptor blockers (ARBs) represent a new class of antihypertensive drugs. The mechanism of action of ARB differs from angiotensin-converting (ACE) enzyme inhibitors, which also affect the renin-angiotensin system. The eight ARBs as antihypertensive approved by the FDA were candasartan, telmisartan, valsartan, losartan, irbesartan, eprosartan, olmesartan, azilsartan, while the ninth ARBs approved by the Korea Food and Drug Administration was fimasartan. ARB has a clinical profile that is very similar but it has a different pharmacokinetic profile.

Keywords: Angiotensin II receptor blockers different pharmacokinetic profile.


[Full Text Article]  [Download Certificate]

Call for Paper

World Journal of Pharmaceutical Research (WJPR)
Read More

Email & SMS Alert

World Journal of Pharmaceutical Research (WJPR)
Read More

Article Statistics

World Journal of Pharmaceutical Research (WJPR)
Read More

Online Submission

World Journal of Pharmaceutical Research (WJPR)
Read More